Form 4: Lemaitre Vascular Director John O'Connor Reports Acquisition of Dividend Equivalent Rights
SEC Form 4 Filing
Director John O'Connor reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.
Summary
- On March 28, 2024, John O'Connor, a director of Lemaitre Vascular Inc., reported the acquisition of dividend equivalent rights.
- These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
- The dividend equivalent rights vest proportionately with the underlying awards and are economically equivalent to shares of Lemaitre Vascular's common stock.
- The acquisitions include 0.476 rights related to a 2021 RSU award, 0.9644 rights related to a 2022 RSU award, 0.9644 rights related to a 2022 PSU award, and 1.2345 rights related to a 2023 RSU award.
- Following these transactions, O'Connor directly owns 6.9143, 5.9511, 4.9624 and 1.2345 dividend equivalent rights respectively.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding the acquisition of dividend equivalent rights, which is a neutral event.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects the ongoing accrual of dividend equivalent rights on previously granted equity awards.
Stakeholder Impact
- The acquisition of dividend equivalent rights has a minor impact on shareholders as it relates to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 12/11/2021 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit and performance share unit award grants related to dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 03/28/2024 | Date of transaction: Acquisition of dividend equivalent rights. |
| 04/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.